1. Home
  2. SCLX vs MOGO Comparison

SCLX vs MOGO Comparison

Compare SCLX & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • MOGO
  • Stock Information
  • Founded
  • SCLX 2011
  • MOGO 2003
  • Country
  • SCLX United States
  • MOGO Canada
  • Employees
  • SCLX N/A
  • MOGO N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • MOGO
  • Sector
  • SCLX Health Care
  • MOGO
  • Exchange
  • SCLX Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • SCLX 35.7M
  • MOGO 42.5M
  • IPO Year
  • SCLX N/A
  • MOGO N/A
  • Fundamental
  • Price
  • SCLX $18.73
  • MOGO $2.01
  • Analyst Decision
  • SCLX Strong Buy
  • MOGO Strong Buy
  • Analyst Count
  • SCLX 3
  • MOGO 1
  • Target Price
  • SCLX $367.50
  • MOGO $4.00
  • AVG Volume (30 Days)
  • SCLX 309.9K
  • MOGO 269.9K
  • Earning Date
  • SCLX 08-13-2025
  • MOGO 11-05-2025
  • Dividend Yield
  • SCLX N/A
  • MOGO N/A
  • EPS Growth
  • SCLX N/A
  • MOGO N/A
  • EPS
  • SCLX N/A
  • MOGO 0.12
  • Revenue
  • SCLX $44,236,000.00
  • MOGO $30,265,570.00
  • Revenue This Year
  • SCLX $89.26
  • MOGO $61.97
  • Revenue Next Year
  • SCLX $203.95
  • MOGO $4.03
  • P/E Ratio
  • SCLX N/A
  • MOGO $16.74
  • Revenue Growth
  • SCLX N/A
  • MOGO 0.18
  • 52 Week Low
  • SCLX $3.60
  • MOGO $0.74
  • 52 Week High
  • SCLX $39.90
  • MOGO $3.83
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 46.04
  • MOGO 58.62
  • Support Level
  • SCLX $14.80
  • MOGO $1.77
  • Resistance Level
  • SCLX $30.90
  • MOGO $2.07
  • Average True Range (ATR)
  • SCLX 3.47
  • MOGO 0.11
  • MACD
  • SCLX -1.47
  • MOGO 0.01
  • Stochastic Oscillator
  • SCLX 23.68
  • MOGO 70.00

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

Share on Social Networks: